SHP-1 phosphorylation is abolished and SHP-2 phosphorylation is increased under hyperglycemia, suggesting that JAK sustained activation under hyperglycemia is partly due to decreased SHP-1 and increased SHP-2 phosphorylation [85,86,87,88,89,90]. Here, PTPN11 is linked to Hyperglycemia.